LXEO logo

Lexeo Therapeutics, Inc. Common Stock

LXEO
Healthcare|Biotechnology|US
$2.89
-0.01 (-0.52%)
DCF Value
$0.95
Tangible Book / Share
$2.75
Cash / Share
$2.47
Next Earnings Report
Dec 14, 2026
EPS est. -$0.32
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Oct 29, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November
Nov 2, 2026 · GlobeNewsWire
Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM
Oct 19, 2026 · GlobeNewsWire
Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
Oct 8, 2026 · GlobeNewsWire
Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson's Disease and Movement Disorders 2026 (MDS)
Oct 1, 2026 · GlobeNewsWire
Apertura Gene Therapy to Provide Lexeo Therapeutics Access to TfR1 CapX™ for Program Designed to Treat Friedreich Ataxia
Sep 23, 2026 · PRNewsWire
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
Sep 23, 2026 · GlobeNewsWire
Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia
Sep 22, 2026 · GlobeNewsWire
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
Sep 2, 2026 · GlobeNewsWire
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
Aug 12, 2026 · GlobeNewsWire

SEC Filings (113)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 2026EFFECTDocumentIndex
Oct 29, 2026S-3Shelf registrationDocumentIndex
Oct 13, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 29, 20268-KMaterial eventDocumentIndex
Sep 22, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 202610-QQuarterly reportDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Aug 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 29, 20268-KMaterial eventDocumentIndex
Jun 15, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 11, 202610-QQuarterly reportDocumentIndex
May 11, 20268-KMaterial eventDocumentIndex
Apr 30, 2026ARSAnnual report to holdersDocumentIndex
Apr 30, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 30, 20268-KMaterial eventDocumentIndex
Apr 13, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 30, 2026S-8Employee stock planDocumentIndex
Mar 30, 202610-KAnnual reportDocumentIndex
Mar 30, 20268-KMaterial eventDocumentIndex
Mar 27, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 5, 20268-KMaterial eventDocumentIndex
Jan 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 29, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 27, 20268-KMaterial eventDocumentIndex
Jan 21, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Dec 8, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 26, 2025EFFECTDocumentIndex
Nov 26, 2025424B3Offering prospectusDocumentIndex